NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Park Medi World Shares to See 21% Upside Potential

Park Medi World shares will be in focus during Friday's trading session, with analysts at Choice Institutional Securities predicting a 21 percent upside potential in the stock. The domestic brokerage has maintained its 'BUY' rating and revised its target price for the company.

The brokerage values Park Medi World at 18 times enterprise value to earnings before interest, tax, depreciation, and amortization (EV/EBITDA) on a fiscal year 2028 estimate (FY28E). This valuation has led to a revised target price of INR 350, up from INR 320.

As of the latest market settlement, Park Medi World shares were trading at Rs 286.47 per share on the National Stock Exchange (NSE). The domestic brokerage is optimistic about the company's growth prospects, predicting more than 22 percent upside potential in the stock. The revised price target of Rs 350 per share reflects this optimism.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Park Medi World's management believes that its cluster-based approach is a key competitive advantage. By sharing doctors, clinical expertise, equipment, and operational resources among hospitals within close geographic proximity, the company is able to enhance utilisation levels, improve talent recruitment and retention, strengthen brand recall, and drive synergies across its network.

ParameterValue
EV/EBITDA (FY28E)18x
Target Price (INR)350
Upside Potential21%
Current Share Price (Rs)286.47

Investor Takeaway

Investors may consider buying Park Medi World shares due to the brokerage's 22% upside projections.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.